Tharimmune (THAR) Stock Chart & Stock Price History $4.97 +1.38 (+38.44%) Closing price 08/21/2025 04:00 PM EasternExtended Trading$4.78 -0.19 (-3.72%) As of 04:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 67.91%, with a year-to-date return of 144.83%. In the past month, the stock has increased 206.79%, reflecting recent market activity. As of the latest close, Tharimmune traded at $4.97 with a market cap of $23.06 million and volume of 113.00 million shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+268.15%1 Month Performance+206.79%3 Month Performance+262.77%Year-To-Date Performance+144.83%1 Year Performance+67.91% THAR Stock Chart for Friday, August, 22, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$3.59$4.97+38.44%$6.09$4.13113.00 million shs$23.06 million08/20/2025$1.17$3.59+206.84%$4.05$1.34354.19 million shs$16.66 million08/19/2025$1.30$1.17-10.00%$1.27$1.08126,411 shs$4.94 million08/18/2025$1.35$1.30-3.70%$1.37$1.2731,138 shs$6.03 million08/15/2025$1.32$1.35+2.27%$1.35$1.2623,577 shs$5.70 million08/14/2025$1.32$1.32$1.32$1.1576,036 shs$5.57 million08/13/2025$1.40$1.32-5.71%$1.66$1.281.67 million shs$5.57 million08/12/2025$1.20$1.40+16.67%$1.41$1.2251,827 shs$5.91 million08/11/2025$1.23$1.20-2.76%$1.30$1.1744,549 shs$5.06 million08/08/2025$1.26$1.23-2.06%$1.26$1.236,256 shs$5.21 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$1.21$1.26+4.13%$1.32$1.2218,033 shs$5.32 million08/06/2025$1.22$1.21-0.82%$1.26$1.2019,132 shs$5.11 million08/05/2025$1.33$1.22-8.27%$1.35$1.2081,302 shs$5.15 million08/04/2025$1.24$1.33+7.26%$1.36$1.2463,235 shs$5.61 million08/01/2025$1.25$1.24-0.72%$1.26$1.2117,180 shs$3.30 million07/31/2025$1.32$1.25-5.38%$1.32$1.2510,958 shs$3.32 million07/30/2025$1.34$1.32-1.49%$1.34$1.3137,369 shs$3.51 million07/29/2025$1.46$1.34-8.22%$1.47$1.3460,710 shs$3.56 million07/28/2025$1.49$1.46-2.28%$1.53$1.4614,404 shs$3.89 million07/25/2025$1.53$1.49-2.35%$1.54$1.4930,817 shs$3.98 million07/24/2025$1.66$1.53-7.83%$1.65$1.5035,893 shs$4.07 million07/23/2025$1.62$1.66+2.47%$1.66$1.6119,303 shs$4.42 million07/22/2025$1.66$1.62-2.64%$1.68$1.6210,013 shs$4.31 million07/21/2025$1.69$1.66-1.54%$1.70$1.6583,820 shs$4.43 million Related Companies Q32 Bio Stock Chart Reviva Pharmaceuticals Stock Chart Elevation Oncology Stock Chart Adaptimmune Therapeutics Stock Chart Aytu BioPharma Stock Chart Moleculin Biotech Stock Chart Passage Bio Stock Chart Aspire Biopharma Stock Chart Finch Therapeutics Group Stock Chart Cingulate Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access